| Dr Arvind Bhandari, MD | |
|
1350 First Colony Blvd, Sugar Land, TX 77479-4308 | |
| (281) 277-5200 | |
| (281) 277-7295 |
| Full Name | Dr Arvind Bhandari |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 51 Years |
| Location | 1350 First Colony Blvd, Sugar Land, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649212804 | NPI | - | NPPES |
| 121319105 | Medicaid | TX | |
| 8R1395 | Other | TX | BLUE CROSS OF TEXAS |
| 121319107 | Medicaid | TX | |
| 121319109 | Medicaid | TX | |
| 121319108 | Medicaid | TX | |
| 121319106 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | F0883 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hermann Sugar Land Hospital | Sugar land, TX | Hospital |
| Houston Methodist Sugarland Hospital | Sugar land, TX | Hospital |
| Memorial Hermann Hospital System | Houston, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Texas Oncology Pa | 5395658934 | 855 |
News Archive
Cold Spring Harbor Laboratory Press announced the release of Metastasis: Mechanism to Therapy, available on its website in Hardcover format.
Insights from a genetic condition that causes brain cancer are helping scientists better understand the most common type of brain tumor in children.
Myriad Genetics, Inc. today announced that it has signed an agreement to acquire proprietary technology for the diagnosis and prognosis of malignant melanoma using highly validated genetic markers from Melanoma Diagnostics, Inc. of Altadena, California. Under the agreement, Myriad has the right to commercialize all tests derived from the technology on a worldwide basis in exchange for upfront fees and contingent payments based upon the commercial success of the products.
New research has discovered that a device they call an "electronic nose" can identify patients with lung cancer by detecting specific compounds in their breath.
› Verified 1 days ago
| Entity Name | Texas Oncology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811944101 PECOS PAC ID: 5395658934 Enrollment ID: O20031124000323 |
News Archive
Cold Spring Harbor Laboratory Press announced the release of Metastasis: Mechanism to Therapy, available on its website in Hardcover format.
Insights from a genetic condition that causes brain cancer are helping scientists better understand the most common type of brain tumor in children.
Myriad Genetics, Inc. today announced that it has signed an agreement to acquire proprietary technology for the diagnosis and prognosis of malignant melanoma using highly validated genetic markers from Melanoma Diagnostics, Inc. of Altadena, California. Under the agreement, Myriad has the right to commercialize all tests derived from the technology on a worldwide basis in exchange for upfront fees and contingent payments based upon the commercial success of the products.
New research has discovered that a device they call an "electronic nose" can identify patients with lung cancer by detecting specific compounds in their breath.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Arvind Bhandari, MD Po Box 911230, Dallas, TX 75391-1230 Ph: (972) 997-8000 | Dr Arvind Bhandari, MD 1350 First Colony Blvd, Sugar Land, TX 77479-4308 Ph: (281) 277-5200 |
News Archive
Cold Spring Harbor Laboratory Press announced the release of Metastasis: Mechanism to Therapy, available on its website in Hardcover format.
Insights from a genetic condition that causes brain cancer are helping scientists better understand the most common type of brain tumor in children.
Myriad Genetics, Inc. today announced that it has signed an agreement to acquire proprietary technology for the diagnosis and prognosis of malignant melanoma using highly validated genetic markers from Melanoma Diagnostics, Inc. of Altadena, California. Under the agreement, Myriad has the right to commercialize all tests derived from the technology on a worldwide basis in exchange for upfront fees and contingent payments based upon the commercial success of the products.
New research has discovered that a device they call an "electronic nose" can identify patients with lung cancer by detecting specific compounds in their breath.
› Verified 1 days ago
Vandana Khera, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 18717 University Blvd Bldg 2, Suite 105, Sugar Land, TX 77479 Phone: 281-208-3322 Fax: 281-208-3393 | |
Susan Vijayan Mathew, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 16811 Southwest Fwy Fl 3, Sugar Land, TX 77479 Phone: 281-275-0897 | |
Saif K Altaie, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 16655 Southwest Fwy, Sugar Land, TX 77479 Phone: 281-274-7000 | |
Priya N. Oolut, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 16659 Southwest Fwy Ste 421, Sugar Land, TX 77479 Phone: 281-325-0005 Fax: 713-512-2247 | |
Dr. Htut Kyaw Win, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 16605 Southwest Fwy Ste 360, Sugar Land, TX 77479 Phone: 713-790-0841 Fax: 713-790-9963 | |
Cathlyn Anderson, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 15200 S Us 59 Highway Suite 360, Sugar Land, TX 75075 Phone: 832-237-3500 Fax: 832-237-0200 | |
Angela Denise Mcgee, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 11555 University Blvd, Sugar Land, TX 77478 Phone: 713-442-9100 |